Publications:

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.

Ebiomedicine

Hoyer, K K; Hablesreiter, R R; Inoue, Y Y; Yoshida, K K; Briest, F F; Christen, F F; Kakiuchi, N N; Yoshizato, T T; Shiozawa, Y Y; Shiraishi, Y Y; Striefler, J K JK; Bischoff, S S; Lohneis, P P; Putter, H H; Blau, O O; Keilholz, U U; Bullinger, L L; Pelzer, U U; Hummel, M M; Riess, H H; Ogawa, S S; Sinn, M M; Damm, F F

Publication Date: 2021-04

Variant appearance in text: KMT2C: 2404delT; S802fs

PubMed Link: 33862582

Variant Present in the following documents:

• mmc3.xlsx, sheet 2

View BVdb publication page

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.

Gut

Yu, Jun J; Wu, William K K WK; Li, Xiangchun X; He, Jun J; Li, Xiao-Xing XX; Ng, Simon S M SS; Yu, Chang C; Gao, Zhibo Z; Yang, Jie J; Li, Miao M; Wang, Qiaoxiu Q; Liang, Qiaoyi Q; Pan, Yi Y; Tong, Joanna H JH; To, Ka F KF; Wong, Nathalie N; Zhang, Ning N; Chen, Jie J; Lu, Youyong Y; Lai, Paul B S PB; Chan, Francis K L FK; Li, Yingrui Y; Kung, Hsiang-Fu HF; Yang, Huanming H; Wang, Jun J; Sung, Joseph J Y JJ

Publication Date: 2015-04

Variant appearance in text: MLL3: 2404delT

PubMed Link: 24951259

Variant Present in the following documents:

• gutjnl-2013-306620-s14.pdf

View BVdb publication page